Department of Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan.
Shobara City Soryo Clinic, Shobara, Japan.
Curr Pharm Des. 2019;25(6):685-692. doi: 10.2174/1381612825666190329122024.
Earlier studies have shown that visit-to-visit blood pressure (BP) variability (VVV) served as a significant independent risk factor of stroke, specifically, in the high-risk elderly of cardiovascular disease (CVD). Although the mechanism is not clearly understood, arterial remodeling such as carotid artery, coronary artery and large aortic artery would be a strong moderator in the relationship between VVV and CVD incidence. Recent studies have provided evidence that VVV predicted the progression of arterial stiffness. While the class of antihypertensive agents is suggested to be an important determinant of VVV, long-acting calcium channel blockers use (CCBs) is associated with the reduction of VVV, and thus, is suggested to decrease the arterial stiffness. Specifically, the relationship between VVV and coronary arterial remodeling has never been reviewed until now. This article summarizes the recent literature on these topics. In the elderly hypertensives, strict BP control using CCBs could play a pivotal role in suppressing arterial stiffening via VVV reduction.
先前的研究表明,血压变异性(VVV)是中风的一个重要独立危险因素,特别是在心血管疾病(CVD)高危的老年人群中。尽管其机制尚不清楚,但颈动脉、冠状动脉和大主动脉等动脉重构是 VVV 与 CVD 发生率之间关系的一个强有力的调节因素。最近的研究提供了证据表明,VVV 可预测动脉僵硬的进展。虽然抗高血压药物的种类被认为是 VVV 的一个重要决定因素,但长效钙通道阻滞剂的使用(CCBs)与 VVV 的降低有关,因此,被认为可以降低动脉僵硬。具体来说,到目前为止,还没有对 VVV 与冠状动脉重构之间的关系进行综述。本文总结了这些主题的最新文献。在老年高血压患者中,使用 CCBs 严格控制血压可能通过降低 VVV 在抑制动脉僵硬方面发挥关键作用。